RDY
Dr. Reddy's Laboratories Limited
Stock
$12.250.00 (0.00%)Close Oct 2, 2026
Balance sheet
| Line | Mar 2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | — | ₹14.7B | ₹7.1B | ₹5.8B | ₹14.9B | ₹14.8B | ₹2.1B | ₹2.2B | ₹2.6B | ₹3.9B | — |
| Inventory | — | ₹71.1B | ₹63.6B | ₹48.7B | ₹50.9B | ₹45.4B | ₹35.1B | ₹33.6B | ₹29.1B | ₹28.5B | — |
| Current assets | — | ₹250.1B | ₹248.0B | ₹204.3B | ₹181.9B | ₹148.2B | ₹130.4B | ₹114.5B | ₹109.6B | ₹100.4B | — |
| Goodwill | — | ₹11.8B | ₹4.3B | ₹4.2B | ₹4.4B | ₹4.6B | ₹4.0B | ₹3.9B | ₹3.9B | ₹3.8B | — |
| Intangible assets | — | ₹96.8B | ₹37.0B | ₹30.8B | ₹27.2B | ₹35.6B | ₹27.7B | ₹44.4B | ₹44.7B | ₹44.9B | ₹20.8B |
| Total assets | — | ₹493.0B | ₹387.5B | ₹321.9B | ₹292.8B | ₹265.5B | ₹232.2B | ₹225.4B | ₹225.6B | ₹219.8B | — |
| Current liabilities | — | ₹130.4B | ₹96.0B | ₹85.8B | ₹94.0B | ₹83.4B | ₹72.8B | ₹59.7B | ₹69.7B | ₹85.0B | — |
| Long-term debt | — | ₹7.9B | ₹6.0B | ₹1.3B | ₹5.7B | ₹6.3B | ₹1.3B | ₹22.0B | ₹25.1B | ₹5.4B | — |
| Total liabilities | — | ₹155.8B | ₹107.0B | ₹90.9B | ₹102.3B | ₹92.4B | ₹77.3B | ₹85.2B | ₹99.1B | ₹95.8B | — |
| Shareholders' equity | — | ₹333.4B | ₹280.6B | ₹231.0B | ₹190.5B | ₹173.1B | ₹155.0B | ₹140.2B | ₹126.5B | ₹124.0B | ₹128.3B |
| Shares outstanding | 834.7M | 834.5M | 166.8M | 166.5M | 166.4M | 166.3M | 166.2M | 166.1M | 165.9M | — | — |
| Current ratio | — | 1.92 | 2.58 | 2.38 | 1.93 | 1.78 | 1.79 | 1.92 | 1.57 | 1.18 | — |